Submitted by Anonymous (not verified) on 5 August 2025 - 15:15
Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised